Loading...

Fagron NV

ARSUF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$26.53
$0.00(0.00%)
U.S. Market opens in 14h 20m

Fagron NV (ARSUF) Stock Overview

Explore Fagron NV’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.9B
P/E Ratio18.08
EPS (TTM)$1.45
ROE0.17%
Fundamental Analysis

AI Price Forecasts

1 Month$26.94
3 Months$25.86
1 Year Target$27.56

ARSUF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Fagron NV (ARSUF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 29.50, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $27.56.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 18.08 and a market capitalization of 1.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
-0.23%
1-Month Change
-1.74%
3-Month Change
12.89%
6-Month Change
12.89%
Year-to-Date (YTD) Change
12.89%
1-Year Change
32.45%
3-Year Change
41.49%
5-Year Change
17.65%
All-Time (Max) Change
-51.38%

Contact Information

https://www.fagron.com
32 8 001 28 80
Venecoweg 20A, Nazareth, NaN, 9810

Company Facts

3,828 Employees
IPO DateFeb 21, 2017
CountryBE
Actively Trading

Frequently Asked Questions